Filter
291
Filtered Results: 291
Text search:
Peter
Johnson
Featured
Recommendations
31
New Publications
67
Language
Document type
No document type
167
Studies & Reports
47
Guidelines
36
Manuals
23
Training Material
11
Strategic & Response Plan
4
Fact sheets
2
Situation Updates
1
Countries / Regions
Global
17
Liberia
8
Nigeria
5
Uganda
5
Kenya
5
Ukraine
5
Western and Central Europe
5
Sierra Leone
4
Zambia
4
Indonesia
4
Malawi
4
Guinea
3
Ethiopia
3
Cameroon
3
Ghana
3
South Sudan
3
Germany
3
Rwanda
3
Bangladesh
3
Eswatini/ Swaziland
3
India
2
Nepal
2
Brazil
2
Lesotho
2
Eastern Europe
2
Southern Africa
2
Russia
2
Senegal
1
Congo, Democratic Republic of
1
Mali
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Togo
1
Zimbabwe
1
Philippines
1
Syria
1
Chad
1
Tanzania
1
Gambia
1
China
1
South Africa
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Middle East and North Africa
1
South–East Asia Region
1
Latin America and the Carribbean
1
Eastern Europe and Central Asia
1
Africa
1
Estonia
1
Iran
1
Authors & Publishers
Publication Years
Category
Countries
70
Clinical Guidelines
29
Women & Child Health
16
Key Resources
15
Public Health
11
Capacity Building
5
Pharmacy & Technologies
2
Toolboxes
Mental Health
41
HIV
35
COVID-19
17
TB
16
Disability
14
Caregiver
13
Planetary Health
12
Ebola
11
AMR
6
NTDs
6
Health Financing Toolbox
6
Conflict
5
Natural Hazards
5
Global Health Education
5
Social Ethics
5
Rapid Response
4
NCDs
4
Pharmacy
3
Refugee
1
Zika
1
Specific Hazards
1
Le rapport 2020 sur la situation du personnel infirmier dans le monde : investir dans la formation, l’emploi et le leadership est publié alors que le monde assiste à un engagement politique sans précédent en faveur de la couverture sanitaire universelle. Parallèlement, notre capacité de pré...
An Indicator-based Approach - This manual presents an indicator-based approach for rapidly assessing pharmaceutical management systems and programs. The manual contains a set of 46 indicators of performance, grouped under eight topics of pharmaceutical management, with each topic being covered by a ...
Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended
2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,...
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.
A paper presented at the 10th International Congress on Infectious Disease, Singapore
Available in: English, French, Chinese, Spanish, Russian, Arabic, Thai, Korean, Tajik, Vietnamese, Uzbek
http://www.who.int/disabilities/cbr/guidelines/en/
This new edition and fully updated publication replaces the 2012 UCG and is being circulated free of charge to all public and private sector prescribers, pharmacists, and regulatory authorities in the country
MMWR Morbidity and Mortality Weekly Report December 19, 2014 / 63(50);1205-1206
Disaster Recovery Toolkit
These guidelines – an update to the World Health Organization’s 2015 publication Consolidated strategic information guidelines – present a set of essential aggregate indicators and guidance on choosing, collecting and systematically analysing strategic information to manage and monitor the nat...
the Lancet : Published Online July 31, 2015 http://dx.doi.org/10.1016/S0140-6736(15)61117-5
The objectives of the meeting were to agree on coordinated and aligned support to the 3 countries’ national health recovery plans (Guinea, Liberia, Sierra Leone); to identify cross-cutting areas and opportunities for integration; to identify ways to improve implementation modalities; and to identi...
Lancet Glob Health 2015; 3: e396–409. Open Access
The new WHO guidelines recommend that people living with HIV be started on antiretrovirals (ARVs) as soon as possible after being diagnosed. Currently, many people living with the virus globally must wait until their CD4 counts fall to 500 to start treatment. According to the WHO, the move to early ...
